| [1] |
Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
|
| [2] |
Sathiakumar N,Delzell E,Morrisey MA,et al.Mortality following bone metastasis and skeletal-related events among women with breast cancer:a population-based analysis of U.S.Medicarebeneficiaries，1999-2006[J].Breast Cancer Res Treat,2012,131(1):231-8.
|
| [3] |
Trinkaus M，Simmons C，Myers J，et al.Skeletal-related events(SREs) in breast cancer patientswith bone metastases treated in the nontrial setting[J].Support Care Cancer,2010,18(2):197-203.
|
| [4] |
Jensen A,Jacobsen JB,Nrgaard M,et al.Incidence of bone metastases and skeletal-relatedevents in breast cancer patients:a population-based cohort study in Denmark[J].BMC Cancer，2011,11:29.
|
| [5] |
Liu H,Xun P,Chen KX,et al.The trend of cIinical characteristics and pmlmosis of women′s breastcancer 1981-2000[J].Zhonghua Yi Xue Za Zhi,2007,87(34):2405-7.[刘红,荀培,陈可欣,等.天津市近20年女性乳腺癌患者临床病理特点及预后变化趋势分析[J].中华医学杂志，2007,87(34):2405-7.]
|
| [6] |
DeSantis C,Siegel R,Bandi P,et al.Breast Cancer Statistics,2011[J].CA Cancer J Clin，2011,61(6):409-18.
|
| [7] |
Koizumi M，Yoshimoto M，Kasumi F,et al.Post-operative breast cancer patients diagnosedwithskeletal metastasis without bone pain had fewer skeletal-related events and deaths thanthosewith bone pain[J].BMC Cancer，2010,10:423.
|
| [8] |
Machado M,Cruz LS,Tannus G,et al.Efficacy of clodronate，pamidronate，and zoledronate inreducing morbidity and mortality in cancer patients with bone metastasis:a meta-analysis ofrandomized clinical trials[J].Clin Ther，2009,31(5):962-79.
|
| [9] |
Henk HJ,Kaura S.Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan[J].J Med Econ,2012,15(1):175-84.
|
| [10] |
Neville-Webbe HL,Gnant M，Coleman RE.Potential anticancer properties of bisphosphonates[J].Semin Oncol，2010，37 Suppl 1:S53-65.
|
| [11] |
Saad F，Lipton A，Cook R，et al.Pathologic fractures correlate with reduced survival inpatients with malignant bone disease[J].Cancer，2007,110(8):1860-7.
|
| [12] |
Niikura N,Liu J,Hayashi N,et al.Treatment outcome and prognostic factors for patients withbone-only metastases of breast cancer:a single-institution retrospective analysis[J].Oncologist,2011,16(2):155-64.
|
| [13] |
Lee SJ，Park S，Ahn HK,et al.Implications of bone-only metastases in breast cancer:favorablepreference with excellent outcomes of hormone receptor positive breast cancer[J].Cancer ResTreat,2011,43(2):89-95.
|
| [14] |
Yavas O,Hayran M,Ozisik Y.Factors affecting survival in breast cancer patients following bonemetastasis[J].Tumori,2007,93(6):580-6.
|
| [15] |
Brown JE,Cook RJ,Lipton A,et al.Prognostic factors for skeletal complications from metastaticbone disease in breast cancer[J].Breast Cancer Res Treat,2010,123(3):767-79.
|
下载:
